October 2020 – Erbi Biosystems

Press Release

Erbi Biosystems raises $3.8M to expand their platform of microfluidic bioprocess and bioreactor equipment, which enables ultra-high cell density and continuous processing

External Articles

Erbi Biosystems Introduces Intensified and Perfusion Microfluidic Bioreactor with Stirred Tank Performance in Just 2 mL Working Volume

Get in Touch

+1 (617) 299-2800
erbi-info@milliporesigma.com
85 Maple St, Stoneham, MA 02180

Links

Contact
Careers
Privacy Policy
Terms and Conditions

Patents

Erbi owned:
US9176060, US9328962, US9574167, 15/268616

MIT exclusively licensed:
US9422409, US9248421, US7993608, US7367550

© 2022 Merck KGaA, Darmstadt Germany and / or its affiliates. All Rights Reserved. MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.

X